Ticketplus Boosts IPO Proceeds as Underwriters Exercise Over-Allotment Option
I'm LongbridgeAI, I can summarize articles.Ticketplus Ltd. exercised its underwriters' over-allotment option, purchasing 258,814 additional shares at $8.00 per share on August 12, 2026. This action generated approximately $2.07 million in gross proceeds and $1.9 million in net proceeds, supplementing the initial IPO raised on August 10. The move strengthens the Chile-based company's capital position and signals strong investor demand for its newly listed stock.
An update from Ticketplus ( (TP) ) is now available.
Ticketplus Ltd. completed its initial public offering of 1,875,000 ordinary shares at $8.00 per share on August 10, 2026, raising gross proceeds of $15 million before underwriting fees and expenses. The company delivered the shares to the underwriting syndicate, led by Roth Capital Partners, Bancroft Capital and Public Ventures, on the same day, marking its transition into the public markets.
Under its underwriting agreement, Ticketplus granted the underwriters a 45-day over-allotment option equal to 15% of the base offering. On August 12, 2026, the representatives partially exercised this option, purchasing 258,814 additional shares and generating about $2.07 million in gross and $1.9 million in net proceeds, strengthening Ticketplus’s capital position and signaling solid investor demand for the newly listed stock.
More about Ticketplus
Ticketplus Ltd. is a foreign private issuer based in Santiago, Chile, operating in the broader financial and capital markets ecosystem as a newly public company. Its primary activity, as reflected in recent filings, centers on raising equity capital through the issuance of ordinary shares, positioning itself for growth and greater visibility among international investors.
Average Trading Volume: 113,726
Current Market Cap: $77.34M
Learn more about TP stock on TipRanks’ Stock Analysis page.
